Skip to main content

Trinity College Dublin, The University of Dublin

Menu Search

Trinity College Dublin By using this website you consent to the use of cookies in accordance with the Trinity cookie policy. For more information on cookies see our cookie policy.

Profile Photo

Professor John Gilmer

Professor in Pharmaceutical Chemistry (Pharmacy)

Head of School (School Office - Pharmacy & Pharmceut Sci)

  ASPIRIN   BINDING   BIOLOGICAL-MEMBRANES   BUTYRYLCHOLINESTERASE   Design, synthesis and testing of specific enzyme inhibitors   ENZYME SUBSTRATE SPECIFICITIES   HOST-GUEST CHEMISTRY   HYDROLYSIS   IMPROVED DELIVERY   Isosorbide-based therapies for Alzheimer's disease   MOLECULAR RECOGNITION   PRODRUG   Pro-drug design for tissue targeting   RECEPTORS   STEROIDS   Thyrotropin-releasing hormone-degrading ectoenzyme inhibitors in the treatment of CNS disorders
 Development of novel aspirin prodrugs
 Probing the interaction of ursodeoxycholic acid with the steroid receptor
 Investigation into highly potent inhibitors of butyrylcholinesterase

Details Date
Member, DMMC Cancer Principal Investigators, Trans-institutional grouping of Principal Investigators leading research on Cancer themes
Member, Core Technology PI's, DMMC Principal Investigators leading the development of core technology platforms.
Member, Centre for Research into Global Disease (Proposed), This consortium combines researchers with complementary interests in globally significant infectious disease. Interests include innate immunity, immune regulation, regional immunity, immune evasiob, vaccine & adjuvant development as well as drug & target development.
Invitee, Colorectal & GI Cancer Research Group (Proposed), Speculative idea to cluster PI's around collaborative study on Upper GI and Colon Cancers.Deliberately wide selection of surgeons, pathologists and academic researchers based on stated interest or publication in fields of oesophageal or colorectal cancer.To be reviewed/focused by DK/JR/PMacM.Extracted from DMMC Research Database - 8 Nov 2004.
Member, PHG Funded PI's and Researchers, All Researchers funded under Cycle 3 PRTLI - Programme for Human Genomics
Details Date From Date To
Member of European Federation of Pharmaceutical Scientists
Murnane C., Gardiner N., Crehan O., Bacon C.L., McHugh R., Gilmer J.F., Mantalaris A., Panoskaltsis N., Chimeric Antigen Receptor-T (CAR-T) Cells as " Living Drugs ": A Clinical Pharmacist Perspective, Journal of Clinical Pharmacy and Therapeutics, 2024, 2024, Journal Article, PUBLISHED  DOI
John Gilmer, Jason Gavin, 'CoCompounds for use in the treatment of liver disease ', Trinity College Dublin, 2022, 28 April 2023, College of the Holy and Undivided Trinity of Queen Elizabeth near Dublin , Patent, SUBMITTED  URL
Zaufel A, van de Wiel SMW, Yin L, Fauler G, Chien D, Dong X, Gilmer JF, Truong JK, Dawson PA, van de Graaf SFJ, Fickert P, Moustafa T., Secondary (iso)BAs cooperate with endogenous ligands to activate FXR under physiological and pathological conditions., Biochim Biophys Acta Mol Basis Dis, 1867, (8), 2021, p166153 , Journal Article, PUBLISHED  DOI
Quilty F, Freeley M, Gargan S, Gilmer J, Long A., Deoxycholic acid induces proinflammatory cytokine production by model oesophageal cells via lipid rafts., The Journal of steroid biochemistry and molecular biology, 214, 2021, p105987 , Journal Article, PUBLISHED  DOI
Watson C., Spiers J.P., Waterstone M., Russell-Hallinan A., Gallagher J., McDonald K., Ryan C., Gilmer J., Ledwidge M., Investigation of association of genetic variant rs3918242 of matrix metalloproteinase-9 with hypertension, myocardial infarction and progression of ventricular dysfunction in Irish Caucasian patients with diabetes: a report from the STOP-HF follow-up programme, BMC Cardiovascular Disorders, 21, (1), 2021, Journal Article, PUBLISHED  DOI
Quilty F, Byrne AM, Aird J, El Mashad S, Parra-Blanco A, Long A, Gilmer JF, Medina C., Impact of Deoxycholic Acid on Oesophageal Adenocarcinoma Invasion: Effect on Matrix Metalloproteinases., International journal of molecular sciences, 21, (21), 2020, Journal Article, PUBLISHED  DOI
O†sullivan, S. and Wang, J. and Radomski, M.W. and Gilmer, J.F. and Medina, C., Novel barbiturate-nitrate compounds inhibit the upregulation of matrix metalloproteinase-9 gene expression in intestinal inflammation through a CGMP-mediated pathway, Biomolecules, 10, (5), 2020, Notes: [cited By 3], Journal Article, PUBLISHED  DOI
Phipps SM, Garry CE, Kamal S, Johnson JD, Gilmer J, Long A, Kelleher D, Duggan SP., High Content Imaging of Barrett's-Associated High-Grade Dysplasia Cells After siRNA Library Screening Reveals Acid-Responsive Regulators of Cellular Transitions., Cellular and molecular gastroenterology and hepatology, 10, (3), 2020, p601-622 , Journal Article, PUBLISHED  DOI
Krzywonos-Zawadzka A, Franczak A, Olejnik A, Radomski M, Gilmer JF, Sawicki G, Woźniak M, Bil-Lula I., Cardioprotective effect of MMP-2-inhibitor-NO-donor hybrid against ischaemia/reperfusion injury., J Cell Mol Med. , 23, (4), 2019, p2836 - 2848, Journal Article, PUBLISHED  TARA - Full Text
Maria Pigott, Jun Wang, Shane O"Sullivan, Carlos Medina and John F Gilmer , Design of Matrix Metalloproteinase Inhibitors for Inflammatory Bowel Disease , Pharmaceuticals, 27th Annual GP2A Medicinal Chemistry Conference, Nottingham University, 2019/12/6, edited by Shailesh N Mistry, Pascal Marchand, Barrie Kellam , 12, (4), MDPI, 2019, pp179-, Poster, PUBLISHED

Page 1 of 10
Toware Gaseous Mediator Hybrid Drugs in, editor(s)Michael Decker , Design of Hybrid Molecules for Drug Development, Oxford : Elsevier, 2017, pp47-81 , [John F. Gilmer], Book Chapter, PUBLISHED
N Glezeva, C Watson, J Baugh, K McDonald, J Gilmer, C Martin, M Santos Martinez, M Ledwidge, Association between low-dose aspirin use, monocyte biomarkers, matrix metalloproteinases and outcome in HFpEF, BMJ Publishing Group Ltd and British Cardiovascular Society, 102, (supplement 9), 2017, ppA5 , Conference Paper, PUBLISHED
Fran Quilty, "Mechanistic Studies into the Effect of Deoxycholic Acid on Oesophageal Cancer Initiation and Progression", 2016, Notes: [PhD Thesis], Thesis, PUBLISHED
Shivashini Kirthi Jeyarajah, Barry Hall, Mary Hussey, John Gilmer, Jun Wang, Carlos Medina, Deirdre McNamara, Low Infliximab Trough Levels Are Not Predictive of Disease Activity in Clinical Practice, Gastroenterology, 148, (4), 2015, ppS-8Am 65 , Conference Paper, PUBLISHED
S Etzbach, JJ Salomon, F Májer, MN Mohd Najib, CM Lehr, JF Gilmer, C Ehrhardt, Fluorescence-labelled bile acids as novel tools to measure organic anionic transporting polypeptide (OATP) function, AAPS Workshop on Drug Transporters in ADME: From the Bench to the Bedside, Bethesda, MD, 14-16/03/2011, 2011, ppW3020 , Meeting Abstract, PUBLISHED
JJ Salomon, S Etzbach, F Májer, JF Gilmer, CM Lehr, C Ehrhardt, Fluorescent bile acids for the assessment of organic anionic transporting polypeptide (OATP) function, AAPS J, 25th Annual Meeting of the AAPS, Washington, DC, 23-27/10/2011, 13, (S2), 2011, ppT2119 , Meeting Abstract, PUBLISHED


Award Date
Visitng Professor in Medicine Chemistry, University of Wurzburg 2014-
Winner, Big Ideas, Enterprise Ireland for Commercialization in The Life Sciences 2010
i) Enzyme inhibitors . Isosorbide-based inhibitors of butyrylcholinesterase (BuChE) and acetylcholinesterase (AChE): synthesis and biochemistry; the role of BuChE in Alzheimer's disease . Rational design of selective covalent inhibitors of COX-2 . Rational design, synthesis and testing of inhibitors for thyrotropin-releasing hormone-degrading ectoenzyme (TRH-DE) ii) Prodrugs and metabolic hydrolysis . Design and evaluation of aspirin-based antiplatelet agents with reduced gastric toxicity relative to aspirin . Intelligent prodrug carrier systems for targeting corticosteroids to the colon . Exploring metabolic vectors for site specific drug delivery